title: The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
authors.affiliation: Department of Neurology, Newcastle upon Tyne Hospitals Trust, Newcastle upon Tyne, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Duddy
authors.affiliation: Department of Clinical Neurology, Oxford University Hospitals Trust, Oxford, UK.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Palace
mesh_terms: D000068717:Glatiramer Acetate / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000453:epidemiology; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D007155:Immunologic Factors; D000068717:Glatiramer Acetate; D016899:Interferon-beta
keywords: GLATIRAMER ACETATE; HEALTH ECONOMICS; INTERFERON; MULTIPLE SCLEROSIS